🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Status
Terminated
Location
University of Minnesota Masonic Cancer Center
Start Date
2020-09-07
Trial ID
NCT04551885
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This single-center, prospective, open-label, comparator study, blind for ce...
Status
Unknown
Location
Kirill Zykov
Start Date
2020-04-30
Trial ID
NCT04380376
Treatments Being Tested
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
This phase Ib/II trial studies the side effects of IRX-2, cyclophosphamide,...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-04-19
Trial ID
NCT03918499
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184